Aridis Pharmaceuticals Inc. (ARDS) Social Stream



Aridis Pharmaceuticals Inc. (ARDS): $1.13

-0.04 (-3.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Aridis Pharmaceuticals Inc (ARDS) Price Targets From Analysts

Use the tables below to see what analysts covering Aridis Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-02 4 $22 $13 $18 $1.7 958.82%
2021-11-11 4 $19 $10 $15 $1.7 782.35%
2022-01-27 2 $19 $10 $14 $1.7 723.53%

The Trend in the Analyst Price Target


ARDS's average price target has moved down $4.6 over the prior 21 months.

Over the past 42 weeks, ARDS's average upside potential has been 300.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-03 5 22 11 17 7.489 127%
2021-07-10 5 22 11 17 7.205 135.95%
2021-08-01 5 22 17 19 4.990 280.76%
2021-09-19 4 22 13 18 4.020 347.76%
2022-01-27 2 19 10 14 2.010 596.52%

ARDS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


ARDS's average broker recommendation rating improved by 1 over the prior 92 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Aridis Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 392.82% of them.
  • To contextualize these metrics, consider that out of all US stocks, Aridis Pharmaceuticals Inc's number of analysts covering the stock is higher than 54.01% of them.
  • In terms of how Aridis Pharmaceuticals Inc fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -202.67% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, Aridis Pharmaceuticals Inc's average analyst price target is greater than 101.3% of them.

Stocks similar to Aridis Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APVO, ANEB, and ALRN.

Make investment decisions regarding ARDS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.401 seconds.